State Street Corp reduced its position in The Joint Corp. (NASDAQ:JYNT – Free Report) by 1.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 285,338 shares of the company’s stock after selling 3,294 shares during the quarter. State Street Corp’s holdings in Joint were worth $3,264,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently bought and sold shares of JYNT. Renaissance Technologies LLC grew its holdings in shares of Joint by 5.5% in the second quarter. Renaissance Technologies LLC now owns 394,478 shares of the company’s stock valued at $5,546,000 after purchasing an additional 20,400 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in Joint by 9.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 194,139 shares of the company’s stock valued at $2,730,000 after buying an additional 17,268 shares during the period. Clayton Partners LLC grew its stake in shares of Joint by 38.1% in the second quarter. Clayton Partners LLC now owns 186,500 shares of the company’s stock worth $2,622,000 after acquiring an additional 51,500 shares in the last quarter. Douglass Winthrop Advisors LLC increased its position in shares of Joint by 4.1% during the third quarter. Douglass Winthrop Advisors LLC now owns 146,400 shares of the company’s stock worth $1,675,000 after acquiring an additional 5,800 shares during the period. Finally, Verus Capital Partners LLC raised its stake in shares of Joint by 5.9% in the third quarter. Verus Capital Partners LLC now owns 132,955 shares of the company’s stock valued at $1,521,000 after acquiring an additional 7,440 shares in the last quarter. 76.88% of the stock is currently owned by hedge funds and other institutional investors.
Joint Trading Up 0.5 %
JYNT stock opened at $9.95 on Tuesday. The company’s 50 day moving average is $11.21 and its two-hundred day moving average is $11.91. The Joint Corp. has a twelve month low of $8.88 and a twelve month high of $17.82. The stock has a market cap of $149.09 million, a P/E ratio of -8.73 and a beta of 1.57.
Wall Street Analysts Forecast Growth
Read Our Latest Research Report on Joint
Joint Company Profile
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
See Also
- Five stocks we like better than Joint
- How to Use Stock Screeners to Find Stocks
- 3 Must-Hold Stocks with Double-Digit Upside for 2025
- How to Buy Cheap Stocks Step by Step
- Micron: Why Now Is the Time to Be Brave
- Dividend Capture Strategy: What You Need to Know
- 3 Stocks That Wall Street Insiders Can’t Stop Buying
Want to see what other hedge funds are holding JYNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Joint Corp. (NASDAQ:JYNT – Free Report).
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.